本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amphastar Pharmaceuticals

26.60
+0.10000.38%
盤前26.50-0.1000-0.38%09:05 EST
成交量:81.21萬
成交額:2,160.11萬
市值:12.22億
市盈率:11.72
高:26.80
開:26.40
低:26.33
收:26.50
52周最高:40.74
52周最低:20.39
股本:4,595.22萬
流通股本:3,480.31萬
量比:1.99
換手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):2.27
每股收益(LYR):3.29
淨資產收益率:14.84%
總資產收益率:6.74%
市淨率:1.57
市盈率(LYR):8.08

資料載入中...

公司資料

公司名字:
Amphastar Pharmaceuticals
交易所:
NASDAQ
成立時間:
1996
員工人數:
2028
公司地址:
11570 6th Street,Rancho Cucamonga,California,United States
郵編:
91730
電話:
傳真:
- -
簡介:
Amphastar Pharmaceuticals, Inc.是一家加利福尼亞的公司,成立於1996年2月29日,於2004年7月和amphastar製藥公司一家在特拉華成立的公司合併。公司是一家專業製藥公司,主要開發,生產,銷售市場上通用和專用注射和吸入產品,包括投資組合的市場進入壁壘高,通用和專利產品。大多數公司的產品用於住院或緊急護理的臨床設置和主要承包通過集團採購組織和藥品批發商。公司的產品主要分佈在藥企零售。

董事

名稱
職位
Jack Yongfeng Zhang
Director, President, Chief Executive Officer and Chief Scientific Officer
Mary Ziping Luo
Chairman of the Board, Chief Operating Officer and Chief Scientific Officer
Diane G. Gerst
Independent Director
Floyd F. Petersen
Independent Director
Gayle M. Deflin
Independent Director
Howard Lee
Independent Director
Jacob Liawatidewi
Director, Executive Vice President of Sales and Marketing and Corporate Administration Center; President of Amphastar France Pharmaceuticals, S.a.S.
Michael A. Zasloff
Independent Director
Richard Prins
Lead Independent Director
William J. Peters
Director, Principal Accounting Officer, Chief Financial Officer, Executive Vice President, Finance and Treasurer
David Gaugh
Director

股東

名稱
職位
Jack Yongfeng Zhang
Director, President, Chief Executive Officer and Chief Scientific Officer
Mary Ziping Luo
Chairman of the Board, Chief Operating Officer and Chief Scientific Officer
William J. Peters
Director, Principal Accounting Officer, Chief Financial Officer, Executive Vice President, Finance and Treasurer
Jacob Liawatidewi
Director, Executive Vice President of Sales and Marketing and Corporate Administration Center; President of Amphastar France Pharmaceuticals, S.a.S.
Rong Zhou
Senior Executive Vice President, Production Center, Executive Vice President, Scientific Affairs; President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.